Core Viewpoint - The article highlights that Qiming Medical-B (02500) has initiated a patent infringement lawsuit against Edwards Lifesciences in the U.S., marking a significant step in the company's legal strategy to protect its intellectual property rights and enhance its competitive position in the global medical device market [1]. Group 1: Company Actions - Qiming Medical's subsidiary Cardiovalve has filed a lawsuit in the U.S. District Court of Delaware against Edwards, alleging that its PASCAL Precision transcatheter valve repair system infringes on Cardiovalve's U.S. Patent No. 10,702,385 [1]. - This legal action follows Qiming Medical's previous victory in July 2025, where it successfully upheld the validity of its US'385 patent against Edwards [1]. Group 2: Industry Implications - Analysts view this lawsuit as a proactive measure by Qiming Medical to defend its innovations, representing a milestone for Chinese medical device companies in leveraging a robust intellectual property system for global market competition [1].
港股异动 | 启明医疗-B(02500)现涨近8% 子公司在美对Edwards重要产品PASCAL提起专利侵权诉讼